{"pageContent": "Background: The clinical outcome for the individual prostate cancer patient is often difficult to predict, due to lack of reliable independent prognostic biomarkers. We tested DNA ploidy as a prognostic factor for clinical outcome in 186 patients treated with radical prostatectomy.", "metaData": {"source": "Stereotactic body radiation therapy for prostate cancer: the need to assess patient-reported outcomes\nhttps://pubmed.ncbi.nlm.nih.gov/25185085/"}}